Search results
Delaware judge lets more than 70,000 Zantac lawsuits go forward By Reuters
Investing.com· 7 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock.
Motley Fool via Yahoo Finance· 2 days agoAnd investing in a safe, high-yielding dividend stock can make the most of your money. That's why a...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 6 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
Why Things Could Get Worse for Pfizer Stock Before They Get Better
The Motley Fool via AOL· 5 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
Pfizer Inc. (NYSE:PFE) – Experts See The Stock A Different Way Today – Marketing Sentinel
Marketing Sentinel· 5 days agoIn today’s recent session, 11.85 million shares of the Pfizer Inc. (NYSE:PFE) have been traded, and its beta is 0.67. Most recently the company’s share price was $29.38, and ...
China's slowing economy, Xi's government tactics leave American investors wary
CBS News· 6 hours agoAmerican CEOs used to swoon over China. On top of that, the U.S.-China relationship has become...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 2 days agoHere's why they picked Gilead Sciences (NASDAQ: GILD), Organon (NYSE: OGN), and Pfizer (NYSE: PFE)....
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock. | The Motley...
The Motley Fool· 2 days agoGenerating dividend income can be an excellent way to put your cash to work. Pfizer pays a quarterly...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 7 days agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena via Yahoo Finance· 7 days agoTakeda and Pfizer have announced a positive Phase III HD21 trial, evaluating ADCETRIS (brentuximab...